
    
      This is a prospective randomized trial conducted at 4 large teaching hospitals (Brigham and
      Women's Hospital, Massachusetts General Hospital, and Boston Medical Center, Boston,
      Massachusetts, and Mayo Clinic, Rochester, Minnesota).

      Malignancy is determined by pathology. Cancer stage is determined by transabdominal imaging
      and/or endoscopic ultrasound (EUS). Written informed consent is obtained from each of the
      enrolled patients. The study is approved by the Institutional Review Boards at each of the
      participating centers.
    
  